Navigation Links
Control And Prevention Of Three Diseases To Be Discussed: European Commission

The investment of the European Commission would be targeted towards controlling the spread of three major diseases, HIV/AIDS, tuberculosis (TB) and malaria // that are haunting the Asian region. Furthermore, a 'Programme for Action to Confront HIV/AIDS, malaria and TB through External Action' would be launched neat year. The main focus of the programme would be aimed at reducing the financial constraints that prevent the realization of the sixth Millennium Development Goal. The greatest challenge in Asia would be the design of appropriate tools to control and manage these diseases, and improve the availability of the tools in places, where the need is felt the most. The programme would be initiated in the year 2007 and would be completed by the end of 2011. In order to better understand and identify new control strategies in the region, a consultation between the Indian health officials and the European Commission, would be held next month on the 4th of April. The four-day consultation would involve the general public, members of civil society, public and private health sector enterprises, networks formed by people with HIV/AIDS and TB. International, National and regional experiences in combating diseases would be discussed in the consultation called 'Confronting HIV, as well as TB and Malaria: An Asia Stakeholders' Consultation'. It would additionally serve as an opportunity to exchange experiences and ideas, paving way for development of common health strategies. The effect of diseases such as malaria, TB and HIV/AIDS are most felt in the developing and underdeveloped countries in Asia, where a majority of the population is below the poverty line. Furthermore, such individuals have very poor access to health care facilities such as those available in the urban areas, placing a significant burden on the economic development. Although tools have been designed to control and manage these diseases, such tools are not made available to those who ne
'"/>




Page: 1 2

Related medicine news :

1. FDA Approves Birth Control Skin Patch
2. Control of inflammation
3. New Birth Control Pills increase the stroke risk
4. Control of anger disorder connected to Brain Dysfunction
5. WHO Declares Vietnam First Country to Control SARS
6. The Importance Of “ Good ”Control Of Diabetes During Pregnanc
7. Controlling Asthma during Pregnancy
8. Effective Control Of Blood Sugar Levels
9. Controlling Allergies Before They Start
10. Diabetics Can Now Be Able To Control Both Blood Sugar And Their Weight
11. Better Control Of Sugar Levels
Post Your Comments:
(Date:12/2/2008).... 2 TYRX, Inc., a leader in the de...-device products, today announced the appointment ...esponsible for commercial operations. , , M...e medical device industry. Mr. Elliot joins TYRX f...on providing laser-based antimicrobial and vascula...
(Date:12/2/2008)...-- Services form an integral part of most of,orig... has therefore become,essential for service provi...ket to remain competitive and constantly improve t... (Logo: http://www.newscom.com/cgi-bin/prnh...t & Sullivan ( http://www.medicalimaging.frost...
(Date:12/2/2008)...na Health and Solutions Medical Billing Team Up To...s in a Cloud" as a SaaS Application. , ...mber 2, 2008 -- Making medical insurance claims is...st phase of a "Claims in a Cloud" softwa...delling partners Xena Health and Solutions Medical...
(Date:12/2/2008)...es your over-the-phone interpretation vendor conti...ompleted the call? , Wash...rld of over-the-phone interpretation (OPI), every ...r one minute can add up over the course of a billi...anization employs an over-the-phone interpretation...
Breaking Medicine News(10 mins):Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Corporate Modelling Partners Start Selling BPM in Cloud Service 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3
...nder the age of 65 who lacked health insurance for...2 percent in 2005//. The proportion of uninsured r... County to a high of 27.5 percent in Tyrrell Count...icularly acute problem in Eastern North Carolina; ...
...e occurrence of multiple sclerosis (MS) among wome...mained// stable. Data from a voluntary MS registr... men in the U.S. had multiple sclerosis, by 2000, ...ong women, University of Alabama professor of bios...
...model of infantile spasms, improving the likelihoo...oung children// who suffer from these catastrophic...ile spasms are a specific type of epilepsy seizure...The disorder involves a sudden bending forward and...
...ty School of Medicine has helped confirm the relia...ch// individual's genetic makeup. The Stanford gr...e that the genetic test can identify patients who ...is from chronic hepatitis C infection. That means ...
Other Medicine News:Health News:Number of Uninsured in North Carolina on the Rise 2Health News:Women More Vulnerable to Multiple Sclerosis, Research Shows 2Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 2Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 3
(Date:12/1/2008)...Prox1 gene is a two-way switch that, if turned off...ammed so that they lose their identity and become ...IS, Tenn., Dec. 1 Scie...ve discovered that a certain differentiated cell t...uires the constant expression of a gene called Pr...
(Date:12/1/2008)...ecember 1 Following a,R... to procure an MVA-based,third generation smallp...Canada, on behalf of the Canadian Department of Na...n Nordic for the delivery of IMVAMUNE(R). , ...) as part of the,country,s bio-preparedness progr...
(Date:12/1/2008)...wire-FirstCall/ -- Vical Incorporated (Nasdaq: V...n milestone payment from Merck & Co., Inc. bas...ical trial of an investigational plasmid DNA (pDNA...n Vical,s DNA gene delivery technology and encodes...TERT is the subject of separate license agreement....
(Date:11/28/2008)...vember 28 German biotech company,...alized HIV monitoring and,AIDS patient follow-up ... In,the year 2008, 2.5 million patient tests have...hly affordable "CyFlow" system, supporting already... Due to introduction of the,Partec innovation, th...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 1Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 3Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Best treatment for MS may depend on disease subtype 23072 1Best treatment for MS may depend on disease subtype 23072 2Best treatment for MS may depend on disease subtype 23072 3The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 1The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 2The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 3
...S WIRE)--Mar 22, 2007 - Nutra Pharma,Corp. (OTCBB:...,drugs for HIV and Multiple Sclerosis has today an...harm, has received notification of,acceptance of i...n,Immunology special conference issue., The articl...y,for Multiple Sclerosis; a review of the literatu...
...aplatin Demonstrated Statistically,Significant Imp...BERLIN, March 22, 2007 /PRNewswire-FirstCall/ -- P...nced additional data from,the double-blind, random... SPARC trial (Satraplatin and Prednisone Against,R...e 22nd Annual,European Association of Urology Cong...
Other Medicine Technology:Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: